Search clinical trials for: Aurora kinase inhibitor AT9283
Total 7800 results
-
Barbara Ann Karmanos Cancer InstituteAstraZenecaWithdrawn
-
Calico Life Sciences LLCAbbVieRecruitingAdvanced Solid Tumor CancerUnited States, Korea, Republic of, Spain, Israel, Japan, France
-
Tata Memorial HospitalRecruitingCarcinoma, HepatocellularIndia
-
Emory UniversityNational Cancer Institute (NCI); Eisai Co., Ltd.RecruitingUnresectable Hepatocellular Carcinoma | Recurrent Hepatocellular Carcinoma | Stage III Hepatocellular Carcinoma AJCC v8 | Stage IIIA Hepatocellular Carcinoma AJCC v8 | Stage IV Hepatocellular Carcinoma AJCC v8 | Stage IVA Hepatocellular Carcinoma AJCC v8 | Stage IVB Hepatocellular Carcinoma AJCC... and other conditionsUnited States
-
Institute of Hematology & Blood Diseases Hospital...Not yet recruitingAML | Refractory | RelapsedChina
-
Albany Research Institute, Inc.CompletedRosacea, ErythematotelangiectaticUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)TerminatedRecurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Adenocarcinoma of the Lung | Large Cell Lung CancerUnited States
-
PfizerRecruitingUlcerative ColitisFrance
-
Bangabandhu Sheikh Mujib Medical University, Dhaka...Incepta Pharmaceuticals LtdCompletedTofacitinib in the Treatment of Refractory Axial Spondyloarthritis Patients: A Dose Escalation StudyAxial SpondyloarthritisBangladesh
-
Rhizen Pharmaceuticals SACompletedLymphoma, T-Cell, Cutaneous | Lymphoma, T-Cell, PeripheralUnited States
-
Technical University of MunichRecruitingIdiopathic Parkinson´s DiseaseGermany
-
Fred Hutchinson Cancer CenterAstraZenecaRecruitingRecurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic LymphomaUnited States
-
University Hospital, LillePfizerTerminated
-
Fudan UniversityActive, not recruiting
-
University of Colorado, DenverAriad PharmaceuticalsCompletedStage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Extensive Stage Small Cell Lung Cancer | Recurrent Small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Limited Stage Small Cell Lung Cancer | Adenocarcinoma of the LungUnited States
-
Jinnah HospitalCompletedAlopecia Areata | Alopecia Totalis | Alopecia UniversalisPakistan
-
PfizerCompleted
-
PIQUR Therapeutics AGCharite University, Berlin, Germany; University Hospital, Basel, Switzerland; University Hospital Freiburg and other collaboratorsCompletedLymphoma | Non-Hodgkin LymphomaGermany
-
Karus Therapeutics LimitedCompletedLymphoma, B CellUnited States
-
Second Affiliated Hospital, School of Medicine,...Not yet recruiting
-
PfizerRecruiting
-
Tesaro, Inc.CompletedSolid Tumors | LymphomasUnited Kingdom, United States, Taiwan, Spain, Poland
-
AmgenCompleted
-
Northwestern UniversityNational Cancer Institute (NCI); Boehringer Ingelheim; Robert H. Lurie Cancer...Active, not recruitingRecurrent Adult Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A | Fibroblast Growth Factor Basic Form Measurement | FLT3 Internal Tandem DuplicationUnited States
-
Sun Yat-sen UniversityNot yet recruitingCervical Cancer | Cervical CarcinomaChina
-
University of ArizonaNational Cancer Institute (NCI)TerminatedHPV Positive Oropharyngeal Squamous Cell Carcinoma | Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7 | Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7 | CDKN2A-p16 Positive | Stage I Oropharyngeal Squamous Cell Carcinoma AJCC V7 | Stage II Oropharyngeal Squamous Cell Carcinoma...United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Mantle Cell Lymphoma | CD20 Positive | Refractory Mantle Cell Lymphoma | Blastoid Variant Mantle Cell Lymphoma | CCND1 Protein Overexpression | CD5 Positive | FCER2 Negative | Pleomorphic Variant Mantle Cell Lymphoma | t(11;14)(q13;q32)United States
-
Children's Hospital Medical Center, CincinnatiPfizerCompletedSystemic Lupus Erythematosus | Cutaneous LupusUnited States
-
PfizerRecruitingUlcerative ColitisUnited States, Israel, Poland, Canada, Japan, Belgium, Spain, Hungary, Finland, France, Australia, United Kingdom, Germany, Italy, Sweden, Netherlands, Slovakia
-
PfizerCompletedArthritis, RheumatoidFrance
-
PfizerCompletedPsoriatic ArthritisChina
-
PfizerTerminatedPlaque PsoriasisUnited States, Canada
-
PfizerRecruitingActive Psoriatic Arthritis | Active Ankylosing Spondylitis | Active Moderate to Severe Rheumatoid ArthritisKorea, Republic of
-
Emory UniversityNational Cancer Institute (NCI)RecruitingMetastatic Lung Non-Small Cell Carcinoma | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Advanced Lung Non-Small Cell CarcinomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNational Comprehensive Cancer NetworkWithdrawnLiver Cancer | HepatoCellular Carcinoma | Unresectable HepatoCellular CarcinomaUnited States
-
OHSU Knight Cancer InstituteGenentech, Inc.; Oregon Health and Science University; American Association for... and other collaboratorsRecruitingStage II Pancreatic Cancer AJCC v8 | Stage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Metastatic Pancreatic Ductal Adenocarcinoma | Locally Advanced Pancreatic Ductal Adenocarcinoma | Unresectable Pancreatic Ductal AdenocarcinomaUnited States
-
PfizerCompletedNon Small Cell Lung CancerUnited States, Australia
-
Yanfeng HouRecruitingRheumatoid Arthritis | TherapyChina
-
Pharmacyclics Switzerland GmbHJanssen Biotech, Inc., including Johnson & JohnsonEnrolling by invitationLymphoma, B-Cell | Lymphoma, Non-Hodgkin | Solid Tumor | Leukemia, B-cell | Graft Vs Host DiseaseUnited States, Spain, Taiwan, United Kingdom, Australia, Italy, Russian Federation, Czechia, Canada, New Zealand, Korea, Republic of, Ukraine, France, Turkey, Hungary, Poland, Sweden
-
Hutchison Medipharma LimitedRecruitingFollicular Lymphoma | Marginal Zone LymphomaChina
-
H. Lee Moffitt Cancer Center and Research InstituteIncyte CorporationCompletedMyelomonocytic LeukemiaUnited States
-
PIQUR Therapeutics AGRoyal Marsden NHS Foundation Trust; University College London Hospitals; Weill... and other collaboratorsCompletedLymphoma, MalignantUnited States, United Kingdom, Serbia, Bosnia and Herzegovina, France, Israel
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Melanoma | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Recurrent Cutaneous MelanomaUnited States
-
National Cancer Institute (NCI)CompletedAlisertib and Romidepsin in Treating Patients With Relapsed or Refractory B-Cell or T-Cell LymphomasRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Recurrent Mantle Cell Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent High Grade B-Cell Lymphoma With... and other conditionsUnited States
-
Hoffmann-La RocheCompletedLocally Advanced Solid Tumors | Metastatic Solid TumorsUnited States, Korea, Republic of
-
University of Texas Southwestern Medical CenterPfizerRecruiting
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer Center; Milton S. Hershey Medical Center; Stanford University and other collaboratorsActive, not recruitingLymphoma | Leukemia | Solid Tumor | Central Nervous System TumorUnited States, Canada
-
PfizerActive, not recruiting
-
Spectrum Pharmaceuticals, IncWithdrawnLung CancerUnited States, Canada, Belgium, Israel
-
Institute of Biomedical Chemistry, RussiaMoscow Regional Research and Clinical Institute Moniki n.a. M.F. VladimirskiyCompletedRheumatoid ArthritisRussian Federation